Marketing Basics For Scientists And Researchers

Just like any other type of professional or business organization, there’s no denying the fact that scientists and scientific researchers can benefit from investing in modern-day digital marketing. 

By leveraging the internet and having the right tools and resources at your disposal, you can easily attract social media followers, create some hype for your most recent projects and experiments, or simply increase awareness for your lab or research facility. 

Below, we’re exploring online marketing basics for scientists and researchers! 

Know Your Goals

No matter what you’re looking to accomplish, it’s crucial that you set a few clearly defined goals or objectives at the start. 

Having goals will ensure that you make the right decisions along the way. And it will also make it easier to measure your success when everything is said and done. 

That said, you must create goals that are specific and not vague or ambiguous. 

This is why we recommend setting SMART goals, which are Specific, Measurable, Attainable, Realistic, and Timely. 

So rather than saying something like, “My goal is to find funding for my new project,” you should set a much more specific goal, such as: 

“I will raise over $10,000 from local investors by the end of Q3 of 2021,” or “I will write one blog post per day about my most recent scientific endeavour for the rest of July to obtain a minimum of 500 website visitors from search engines like Google.  

Ensuring that your marketing goals stick to these guidelines will help ensure your overall success and that your goals are reasonable and within your reach. 

Make A Plan

The next most crucial step of a successful marketing campaign is to have a plan in place! 

After you’ve set a series of SMART goals, it will become increasingly clear what you’ll need to do to achieve those goals. 

For instance, if your goal is to raise money from local investors, it would be wise to get involved in local science-related events, where you’ll most likely find people who will be interested in supporting your cause. 

Or, if your goal is to generate more traffic on your website, performing keyword research and studying SEO might be more beneficial. 

Either way, the point is to start by knowing your goals and then create a plan on how you’ll try to accomplish them. 

Write your ideas down, keep notes, and don’t be scared to change or tweak your approach as time goes by. 

So, if you realize that you’re going to fall short on one of your goals, it’s going to be better to make a change to your plan now before it’s too late. 

For instance, if your goal is to blog once daily to generate 500 website views, and half the month has gone by, and you’re nowhere near halfway to your destination, you might change your plan to posting a new blog twice per day instead. 

Social Media, SEO And PPC Ads 

Finally, suppose you want to market yourself, either as a scientist or a researcher. In that case, you’ll need to invest some money into building a website, creating social media profiles, and supplementing your organic efforts with paid advertising if necessary. 

You might also want to create a logo and branding to make your website and social profiles look more professional. 

Then, once you’ve got your online presence set up, you’ll need to get active blogging, posting content on social media, and promoting yourself on whatever channels you see fit to help you accomplish your SMART goals. 

Marketing 101 For Lab Workers, Scientists, And Researchers

No matter what type of work you do, online marketing can put you and your business in front of a potentially massive online audience. 

However, it’s essential to realize that successful marketing campaigns take time, and success doesn’t happen overnight. 

So get started today by creating a few SMART goals, working on your plan, and investing some time and effort into your online presence, and before you know it, you’ll be reaping the rewards of your very first marketing campaign! 

-Cary Curry

Pathogenesis

Executive Officer’s Blog

June 1, 2020

Who We Are

We find ourselves in desperate times with unique and overwhelming challenges not unlike the trials and tribulations encountered by past generations of people down through history. We see crises in every direction that we look and it is difficult to know how to respond effectively. History fails to provide guidelines for how to manage through events affecting our civilization that are unprecedented. Beginning in 2019 and throughout 2020, the world has been experiencing a global pandemic that has seen >105,000 deaths in the United States and >370,000 deaths world-wide due to COVID-19. There is no end in plain sight for the pandemic, and science continues to be under attack by those who refuse to accept the reality of the crisis at hand. In the United States and world-wide, the pandemic has amplified economic and social inequities adding to the challenges of everyday survival. People are struggling and many lack a sufficient economic and social safety net. Most recently in the United States, we have seen multiple new violent manifestations of the persistent social injustice encountered by minority populations for decades. We are shocked by what we see and we fail to identify with the perpetrators of the violence or the demonstrators whose protest became violent and destructive in cities across our country. We cannot believe that these kinds of things continue to take place. These are things that matter. In times like these and in response to events like these, it is natural to ask the question: “who are we?”

The answer to this question is important for us as individuals, as citizens of towns, cities, and states, as members of various racial/ethnic groups, as residents of the United States or other countries. This question can be applied to our departments, centers, and institutions, as well as to our profession as a whole. The answer to this question is critical as it defines our community and reflects to a large extent our values and what we stand for. It’s a question that is worth pondering from time to time, and we should not be satisfied with a superficial assessment or snap judgement. The answer is not an end unto itself. The answer can and should help us improve ourselves as individuals and our community as a collective. 

The American Society for Investigative Pathology is above all else a community. Whereas the Society was founded over 100 years ago with a membership that was predominately male and Caucasian, we are now a community that is diverse in every sense of the word. We are inclusive and welcoming. We are men and women. We are young and old. We are working and retired. We work in academia, biotech, industry, non-profits, and government. We are a community of scientists, physicians, physician-scientists, and veterinarians. We were trained in various scientific disciplines and have varied professional experiences. We are a community of basic scientists, clinical investigators, and translational researchers. We work on all aspects of biomedical science, and utilize many different scientific approaches in our research. We live in North America, South America, Europe, Asia, and Africa. We are citizens of many nations. We represent many races, ethnic groups, cultures, and religions. We come from families with varied socioeconomic and educational status. We are not all of the same sexual orientation or identity. We represent different political viewpoints. We are individuals.

While the American Society for Investigative Pathology is diverse, we have strong shared interests. We share in the pursuit of scientific truths, the generation of new knowledge, and an expanded and sophisticated understanding of human diseases. We share the desire to improve the human condition and to rid the world of unnecessary suffering from disease. We share a curiosity for scientific exploration. We value character and reward accomplishment. We share the objective to educate and train the next generation of scientists as we provide a model for them to follow of honest and ethical research practices. We strive for excellence in our work. We are students and teachers. We are mentors and mentees. We embrace diverse research teams. We seek to provide opportunities for those people in search of new training, new positions, and new challenges. We provide support for our peers, our trainees, and our collaborators. We share our knowledge and expertise broadly. We serve the greater good. We are a village.

The American Society for Investigative Pathology offers its members the opportunity to be a part of the kind of community that we want to see in our towns, cities, states, countries, and around the world. The ASIP represents a community where equality is a prime objective and goal, where opportunities are extended to all, where individuals selflessly support others, where the word “peer” in applied broadly, and where labels are used to identify rather than to distinguish. The ASIP community is not yet perfect…it is a living and breathing work in progress that requires intentional thoughts and actions on the part of the members, elected leadership, and staff. Continued progress towards a culture of equality and opportunity will require all of our best efforts. We look forward to working with each of you as we continue on this journey. In the end, we hope and pray that the best qualities of our Society and its members will be reflected in our world-wide society at-large and its citizens.

So, what are we to do now to effect change in our professional society, our institutions, our communities, and the world at-large? Too often we conclude that we cannot individually contribute in a significant manner to problems as large as systemic racism and discrimination against members of specific groups. This mentality paralyzes us into inaction. The problem appears too enormous for the efforts of a single person or a small group of people. However, every positive action that we make chips away at the larger problem, no matter if that problem is in our professional society, our institutions, our communities, or the world at-large. We must endeavor to combat systemic racism and discrimination by providing opportunities to all people, irrespective of race, religion, ethnicity, sexual orientation, country of origin, or other individual characteristics. Through individual actions that are within our power we will effect change at a local level and contribute to culture shifts within our institutions and communities. As Mother Teresa said – “If you cannot feed a hundred people, then feed just one.” We might not be able to provide opportunities to a hundred people, but we can offer opportunities to a few, and that will contribute to the larger solution. Change begins with us.

The Future of the Experimental Biology Meeting

William B. Coleman, PhD 
Executive Officer

* Experimental Biology 2020 Canceled

In the Spring of 1993, in New Orleans, Louisiana, a new multi-society, interdisciplinary, collaborative scientific meeting was held for the first time as Experimental Biology. The meeting consisted of the co-located Annual Meetings of five scientific societies affiliated with the Federation of American Societies for Experimental Biology (FASEB): the American Association of Immunologists (AAI), the American Physiological Society (APS), the American Society for Nutrition (ASN), the American Society for Pharmacology and Experimental Therapeutics (ASPET), and the American Society for Investigative Pathology (ASIP). In 1994, the Experimental Biology meeting expanded to six host Societies with the addition of the American Association for Anatomy (AAA), and in 2005, the Experimental Biology meeting expanded to seven host Societies with the addition of the American Society for Biochemistry and Molecular Biology (ASBMB). ASBMB had participated in the Experimental Biology meetings from 2001-2003 as a guest society. Between 2000-2008, AAI participated in the meeting during select years, and then withdrew completely after Experimental Biology 2008. Following Experimental Biology 2017, ASN withdrew and moved to a stand-alone meeting. Over the years, numerous guest societies have participated in the Experimental Biology meeting enriching it with broader multidisciplinary science. ASIP’s recent guest societies include the American Society for Matrix Biology (ASMB), the American College of Veterinary Pathologists (ACVP), The Histochemical Society (HCS), The Society for Cardiovascular Pathology (SCVP), the Italian Society of Pathology and Translational Medicine (SIPMeT), and the Society for Toxicologic Pathology (STP).

I attended that first Experimental Biology meeting as a postdoctoral fellow, completely unaware that it was the inaugural event of the series of meetings that followed and is now over 25 years-old. Prior to 1993, I had attended other large joint meetings (involving some of these same Societies) and incorrectly assumed that these prior meetings must have also been “experimental biology” meetings. Since 1993, the ASIP has participated in every Experimental Biology meeting with the exception of 1996 (when the ASIP met jointly with two other groups). Hence, Experimental Biology has been the home of the ASIP Annual Meeting for a very long time. Whereas I have not attended every Experimental Biology meeting since 1993, like so many longstanding ASIP members I have attended most and I value the many opportunities that our Annual Meeting at Experimental Biology has provided to me as an ASIP member. The ASIP scientific program, and associated career development and educational events, are always very well planned and exceptional in content. The meeting provides a venue for our members at every stage of career to present their original research and network with other members of the pathology research community. It is always a great event.

In 2019, 26 years after the birth of the Experimental Biology meeting, we find ourselves at a crossroads related to the future of our Annual Meeting. The bad news is that the American Physiological Society (APS) has decided, after considerable study and feedback from their membership, to withdraw from the Experimental Biology meeting. In future years, APS will establish their own world-class meeting for the global physiology community. The good news is that APS will continue to meet with Experimental Biology through 2022. Hence, we can look forward to three more years of the kind of multidisciplinary meeting we have had since 1993. Experimental Biology 2020 will be held in San Diego, California, and our organizing committees (Program Committee, Committee for Career Development and Diversity, and Education Committee) have assembled an exceptional program of scientific sessions and educational/career development events (http://asip20.asip.org/). Experimental Biology 2021 will be held in Indianapolis, Indiana, and the organizing committees are already hard at work planning the scientific sessions and other events. The site for Experimental Biology 2022 has not yet been selected, but promises to be another outstanding meeting.

So…what happens after Experimental Biology 2022The ASIP Council has been discussing possibilities for our future Annual Meetings for over 6 months (based upon the possibility that APS might withdraw from Experimental Biology). While no decisions have been made as of yet, we have several excellent possibilities for future ASIP Annual Meetings. One possibility is that we will continue to meet with other FASEB Societies in a meeting that is similar to Experimental Biology. There’s the possibility that such a meeting might be called something else, and could involve new and different groups representing other scientific disciplines. Another possibility is that we exploit the great successes and best practices of our stand-alone PISA meetings (http://asip.org/meetings/pisa_past.cfm) in the development of a stand-alone Annual Meeting. The PISA meetings have proven to be very popular and we look forward to the next PISA meeting in November of 2020 in Boston, Massachusetts. A third possibility is that we would partner with some new groups (with common interests) to develop collaborative meetings. In the near future, we will conduct a survey for feedback on what types of meetings would be most ideal for advancement of our members’ research, educational, and career development needs and goals. Once this member feedback is in hand, we will move swiftly to make decisions related to 2023 and beyond.

The ASIP Annual Meeting is an important member benefit and it is of tremendous value to members at every career stage. The ASIP Annual Meeting is where we meet our peers in the pathology research community, present our research, and expand our knowledge and skills through scientific sessions, educational events, and career development activities. The Experimental Biology meeting has been good for ASIP members and the ASIP Annual Meeting. It is regrettable to consider that the Experimental Biology may cease to exist. However, from our perspective and looking towards the future, we will focus on the exciting possibilities for continued excellence in our scientific meetings and innovative new ways to expand our Annual Meeting to better serve our membership. We can all look forward to making this new journey together.

For now, make your plans to join us in San Diego for Experimental Biology 2020 and Boston for PISA 2020!

Living and Working in the Era of COVID-19

William B. Coleman, PhD
Executive Officer

A little over two weeks ago, on Friday, March 6th, the Meeting Planners and Executive Officers of the cooperating Societies (AAA, APS, ASBMB, ASPET, and ASIP) reluctantly announced the cancellation of the Experimental Biology 2020 meeting that was scheduled for early April in San Diego, CA. The meeting was cancelled due to concerns over the rapid spread of the COVID-19 virus. At that time, there were few cases in San Diego, but developments from across the nation and globe dictated our decision. We knew that our members from other countries would have difficulty attending the meeting, and daily changes in international travel alerts and bans made it clear that many/most of our international members would be prohibited from traveling to the United States. Furthermore, travel bans imposed by hospitals and medical centers, academic institutions, research organizations, and industry, for physicians (in some cases) and all faculty/staff/students (in other cases) made it clear that the ASIP Annual Meeting would be significantly impacted. When we learned that some of our invited speakers local to San Diego were not being permitted to attend (to avoid large crowds), we knew that we had no choice other than to cancel the meeting. Our hope is that cancelling the meeting a month prior to its scheduled start would give our members time to cancel their travel arrangements and hotel accommodations without penalty. As you have been notified, registration fees will be refunded and abstracts will be published as planned.

Since March 6th (which feels like it was years ago), California declared a state of emergency (as have many other states), the President declared a national emergency, and a number of major cities and states are largely or completely shut down. During the same period of time, the number of cases of COVID-19 infection increased to over 43,925 cases nation-wide* (with >545 deaths recorded). With the rapidly changing landscape of the pandemic and the ultimate mandates against large and small gatherings, our meeting was destined to be cancelled. Given that the health and safety of our members is our major concern, cancellation of the Annual Meeting was and continues to be the right decision. We sincerely hope that all of our members – in the United States and abroad – will adhere to social distancing, respect the suggestions to isolate as much as possible, avoid exposure to COVID-19, and remain healthy. In particular we send well wishes to our members who work as physicians who risk exposure in the clinical setting and/or who are working overtime in hospital laboratories to provide critical molecular testing for patients. Thanks for doing this important work in your cities and communities. We also send well wishes to our members across the globe and hope that everyone is able to remain healthy, particularly our members in the hardest hit areas of United States, Europe, and Asia.

The New Normal
So, we find ourselves in an unprecedented time – as individuals and as a Society. Our collective hope is that this new normal is very temporary and does not repeat itself in the future. The Governor of Maryland has mandated that all non-essential businesses close, and so the ASIP office in Rockville is officially closed. However, ASIP staff members are working remotely and all Society operations are functioning at full capacity. We are dealing with the aftermath of the cancellation of the San Diego meeting, while moving forward with plans for our upcoming meeting in Boston which will be held in November of this year, as well as plans for next year’s Annual Meeting during Experimental Biology 2021 in Indianapolis, IN. We are available to assist members with any issues they may have, and the journal staff is working hard on the next issues of The American Journal of Pathology and The Journal of Molecular Diagnostics. We hope that our members will be able to maintain momentum in their own research programs during this time when laboratories are being forced to close temporarily. We certainly welcome manuscript submissions during this period of time when progress for individual investigators and their labs might be confined to writing up results that are already in hand. Rest assured our peer review network is working hard and reviews will be completed in a timely fashion.

Financial Consequences of the COVID-19 Pandemic
A frequently asked question following the cancellation of the Annual Meeting is “…what are the financial consequences of not holding the meeting?” At this point, we don’t know because we are working through cancellation of all the contracts and filing claims with our insurance broker. In an ideal world, our meeting insurance policy will make us whole. Time will certainly tell. It should be clear to everyone that the COVID-19 pandemic will be associated with great financial costs for all organizations, and the ASIP is no exception. The financial consequences of the pandemic will far exceed losses from the Annual Meeting. This is due to the recent significant downturn in the stock market which impacts our long-term investments/reserves. It will take many months to know if our short-term losses will become long-term losses in this regard. That said, we do not anticipate that COVID-19 pandemic-related financial losses will impact on the ability of the ASIP to continue operating “normally” (or as close to normal as possible under the current circumstances).

Beyond the Financial Costs of COVID-19
The greater cost of the COVID-19 pandemic-associated cancellation of our Annual Meeting for individual ASIP members and the Society as a whole is the loss of opportunity for the member-to-member interactions that occur in the unique atmosphere of the ASIP Annual Meeting. As we all know, at the Annual Meeting our members (senior leaders of the field of experimental pathology, mid-career scientists, newer investigators, and trainees) easily and naturally connect/engage to discuss research and to network. Hence, the Annual Meeting represents a few days of the year that we all value and anticipate. Like the members of our Society, the ASIP staff looks forward to interacting with our members during the meeting each year, to conduct face-to-face business with the ASIP Council, and to engage with members of our working committees. Whereas the staff meets through conference calls and video conferences with the Council and many of our Committees on a regular basis, face-to-face interactions during the Annual Meeting cannot be easily replaced by virtual meetings. With cancellation of the meeting, we also lost opportunities for our members to showcase their science through oral and poster presentations, to recognize trainee travel awardees and trainee meritorious awards (such as the Experimental Pathologist-in-Training award), and to highlight the research of our members receiving major meritorious awards (including the ASIP Rous-Whipple Award, the ASIP Outstanding Investigator Award, and others). For the ASIP, the Annual Meeting is not valued because it represents a source of revenue. Rather, the value of the Annual Meeting, first and foremost, is as a venue to facilitate critical member-to-member interactions in a setting conducive to fostering discussion, engagement, and networking. Hence, we look forward to our next opportunities to interact in a face-to-face manner.

On behalf of the ASIP membership, I would like to offer our sincere thanks to the Program Committee and representatives of various Scientific Interest Groups for assembling an exceptional scientific program for the Experimental Biology 2020 meeting. Likewise, I want to offer thanks to the members of the Committee for Career Development and Diversity (CCDD) and the Education Committee for enhancing the scientific program at EB2020 with career development and educational sessions that are focused on our trainees and young investigators. The members of these three committees worked for well over a year planning the ASIP program for San Diego. We are currently discussing which of these sessions we might carry forward into the Experimental Biology 2021 meeting in Indianapolis, IN. We anticipate that much of the 2020 program will be carried over with minimal modification. In addition, we are looking at the possibility of adding some additional (newly developed) programming to the 2021 schedule. Stay tuned.

In light of all this bad news, there is some good news for ASIP members. In November, we will gather at the Royal Sonesta in Boston for the 2020 PISA meeting. Wheras PISA is a smaller meeting that the Annual Meeting at Experimental Biology, this year’s PISA provides an opportunity for our to regain some of what was lost with the cancellation of EB2020. Therefore, we will declare that PISA2020 is this year’s ASIP Annual Meeting (to fulfill the obligation to hold a scientific meeting each year as dictated by the ASIP Bylaws). The scientific program for PISA2020 was set prior to the cancellation of the San Diego meeting. Hence, we will not be able to move scientific content from EB2020 into PISA2020. However, we will be adding four meritorious award lectures, a number of award presentations, the inaugural Women in Pathology networking/social event, and some necessary face-to-face business to the PISA2020 schedule. We are hopeful that many/most of our 2020 trainee travel awardees will be able to attend the PISA2020 meeting using their awards. The PISA2020 venue at the Royal Sonesta is ideal for a small meeting, but does have limited capacity. So, please stay tuned to announcements related to PISA2020 and be sure to register early to ensure your seat at the meeting.

Moving Forward
We are currently working to ensure that the ASIP membership continues to be well informed of Society activities and news. Please pay attention to your emails and our social media posts in this regard. Several important news items have been released in recent days, including the results of the 2020 Election and announcement of the 2021 Meritorious Awards. In the coming weeks, we anticipate release of a virtual presentation of the ASIP Gold-Headed Cane award to representatives of the University of California at San Diego on behalf of Dr. Marilyn Farquhar. We will also release the slides that were intended for the Business Meeting in San Diego to inform the membership of the major activities of the Society during the past year. As indicated above, the ASIP staff and committees continue to work hard to ensure that future face-to-face meetings will be valuable and successful. Please be sure to contact us if you have questions or concerns or need assistance of some kind. Most importantly, stay safe and healthy as the COVID-19 pandemic persists. We look forward to seeing everyone once the pandemic ends.

*I started composing this blog on Friday, March 20, and the first draft included a figure of about 16,000 as the reported number of cases in the United States. As I continued to work on this blog over the weekend, I have literally had to change this number by the hour as the number of infections appeared to increase exponentially. The final number reflected here was taken from CNN on Tuesday morning, March 24, 2020.

Recap of the 2019 Annual Meeting at Experimental Biology in Orlando, FL

The 2019 Annual Meeting of the American Society for Investigative Pathology was held April 6-9, 2019 in Orlando FL, in conjunction with Experimental Biology 2019. Over 10,000 scientists attended the meeting in the Orange County Convention Center, which was co-organized by the American Association of Anatomists (AAA), the American Physiological Society (APS), the American Society for Biochemistry and Molecular Biology (ASBMB), and the American Society for Pharmacology and Experimental Therapeutics (ASPET). The meeting featured a robust scientific program, featuring 2 meritorious award lectures, 14 major symposia, 5 workshops, 6 sessions dedicated to education and career development, and 10 minisymposia and 25 poster sessions reflecting 398 abstracts. EBTV featured interviews with Dr. David Williams and Dr. Bill Coleman that provided insights into the ASIP scientific program and ASIP involvement in Experimental Biology 2019. Special thanks to the members of the Program Committee (Chaired by Dr. David Williams), the Committee for Career Development and Diversity (Chaired by Dr. Cecelia Yates), and the Education Committee (Chaired by Dr. Diane Bielenberg) for assembling an excellent program for the Annual Meeting. The Annual Meeting also provided ample opportunities for members to network and socialize. This blog will highlight some of the ASIP activities and events that took place during Experimental Biology 2019.


Meeting Support and Guest Societies

The 2019 Annual Meeting was enhanced by the presence and contributions from a number of partnering guest societies, including the Association of Molecular Pathology (AMP), American Society for Matrix Biology (ASMB), Histochemical Society (HCS), Society for Cardiovascular Pathology (SCVP), Society for Toxicologic Pathology (STP), American College of Veterinary Pathologists (ACVP), and the Italian Society of Pathology and Translational Medicine (SIPMeT). Several of these guest societies contributed to the scientific program by organizing a symposium or workshop. The 2019 Annual Meeting was also generously supported by unrestricted educational grants from Fluidigm, Samsara Sciences, Earlier.org, Baker, Coy Lab Products, Peloton Therapeutics, and Elsevier. Support for speakers in some sessions was provided by the R.E. Stowell Endowment Fund. In addition, R13 grants from the NCI and NIEHS supported specific trainee travel awards and session speakers. Some travel awards were also generously provided by the Histochemical Society. We thank the members of the Program Committee and ASIP leadership that provided time and effort to secure sponsors and grants to support the Annual Meeting.


Business Meeting

Each year at the Annual Meeting, a business meeting is held and reports are presented by the President, Committee Chairs, and the Editor-in-Chief of The American Journal of Pathology. The 2019 business meeting was presided over by current ASIP President Dr. Asma Nusrat (University of Michigan). The results of the 2019 election were presented, and the 2020 Meritorious Award recipients were announced. Several meritorious awards for 2019 were presented, along with numerous travel awards (see below). At the end of the meeting, Dr. Nusrat presented the Presidential Gavel to Dr. Dani Zander (University of Cincinnati) who will serve as ASIP President beginning July 1, 2019.


Meritorious Awards and Award Lectures

Each year, a variety of meritorious awards are given by the American Society for Investigative Pathology to recognize outstanding research, teaching, and leadership by senior investigators, mid-career investigators, and early career investigators. At Experimental Biology 2019, three members were recognized with meritorious awards. Dr. Vinay Kumar (Alice Hogge & Arthur A. Baer Distinguished Service Professor and Chairman Emeritus, Department of Pathology, University of Chicago) received the 2019 ASIP Gold-Headed Cane Award, which is the society’s oldest and most prestigious award. This award recognizes long-term contributions to the field of pathology, including meritorious research, outstanding teaching, general excellence in the field, and leadership in pathology. Dr. Kumar delivered a keynote address entitled The Accidental Pathologist – A Curiosity Driven Journey from Plant Evolution to Natural Immunity on Sunday afternoon. Dr. Jerry Turner (Harvard Medical School) introduced Dr. Kumar’s lecture and presented the award. Dr. Gregory J. Tsongalis (Professor, Department of Pathology, Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Dartmouth University) received the 2019 ASIP Robbins Distinguished Educator Award. This award recognizes individuals whose contributions to education in pathology have had a manifest impact at a regional, national, or international level, and is named in honor of Dr. Stanley L. Robbins. Dr. Tsongalis presented lecture entitled Moving Beyond Next-Generation Sequencing: The Role of Stat DNA Testing during the Cancer Biomarkers Workshop on Sunday morning. Dr. Bill Coleman (ASIP) made the award presentation. Dr. Denuja Karunakaran received the 2019 ASIP Young Scientist Leadership Award. This award recognizes outstanding and sustained achievements at the earliest stages of a career in biomedical research and is supported by the A.D. Sobel – ASIP Education Fund. Dr. Bill Muller (Northwestern University) made the award presentation.


Faculty Travel Awards, Trainee Meritorious Awards, and Trainee Travel Awards

Three members received George K. Michalopoulos Junior Faculty Travel Awards to attend Experimental Biology 2019: Dennis Jones, PhD (Boston University), Matthew McMillen, PhD (University of Texas at Austin), and Edward Medina, MD, PhD (University of Texas Health Science Center). These awards promote the participation of early career investigators in scientific meetings and conferences, and recognize the outstanding research being conducted by ASIP Regular and Next-Generation Scientist members who are employed as Junior Faculty at institutions around the world. Special thanks to Dr. George Michalopoulos and his family for recognizing the importance of these awards and providing financial support for them. The Experimental Pathologist-in-Training (EPIT) Award is a prestigious honor presented to an ASIP trainee member who is a postdoctoral fellow and has excelled in investigative efforts in studying mechanisms of disease. The 2019 Experimental Pathologist-in-Training Award was presented to Dr. Shengmin Yan (Indiana University School of Medicine) and the Experimental Pathologist-in-Training Merit Award was presented to Dr. Francisco J. Carrillo-Salinas (Tufts University). The Experimental Pathologist-in-Graduate Training Award is a prestigious honor presented to an ASIP trainee member who is a graduate student in a PhD training program, MD/PhD training program, or MD training program who has excelled in investigative efforts in studying mechanisms of disease. The Experimental Pathologist-in-Graduate Training Award was presented to Njabulo Ngwenyama (Tufts University) and the Experimental Pathologist-in-Graduate Training Merit Award was presented to Patrick D. Wilkinson (University of Pittsburgh). In addition, trainee travel awards were presented to 32 trainee members: Three trainee members received A.D. Sobel Scholar Trainee Travel Awards (Triet Bui, Roberto I. Mota Alvidrez, and Akanksha Sharma); Timothy D. Bryson received the GALL Trainee Travel Award for Excellence in Cardiovascular Research; Orlane Destin received the Gotlieb Family Fund for Undergraduate Education in Pathobiology travel award; Sanaullah Sajib received the Hans-Monga-ASIP Trainee Travel Award for Excellence in Cardiovascular Research; Jacquelyn O. Russell received the Rojkind-Monga-ASIP Trainee Travel Award for Excellence in Liver Pathobiology Research; Hayley Gorman received The Marion and Lawrence (Larry) Muller Memorial Fund-ASIP Trainee Travel Award for Excellence in Inflammation Research; 14 trainees received ASIP Trainee Travel Awards – Marina Anastasiou, Prarthana J. Dalal, Trevor M. Darby, Paul J. Hanson, Kelsey M. Hirschi, Sarah Hosking, Dana R. Julian, Matthias Kelm, Lindsey Kennedy, Yang Lee, Benoit Niclou, Joshua Owens, Morgan E. Preziosi, and Francisco E. Velazquez Planas; and 10 trainees received Histochemical Society Trainee Travel Awards – Ramón Castellanos, Allison Gartung, Vashendriya Hira, Karis P. Kosar, Bejan J. Saeedi, Victoria Hallisey, Jeana L. Owens, Tirthadipa Pradhan-Sundd, Katlyn Richardson, and Kaitlynn Schuck. Special thanks to all the ASIP Members that established and support named trainee travel awards – Drs. Mark Sobel, Paul Monga, Jon Homeister, Avrum Gotlieb, and Bill Muller.


SIG Night and Society-wide Reception and Networking Event

On Sunday afternoon, the Society-wide Scientific Interest Groups Interactive Poster Discussions, Networking Sessions, and Reception was held immediately following Dr. Kumar’s keynote lecture. The Sunday afternoon/evening placement of these events was very popular and >250 people attended the reception. The SIG Night Interactive Poster Discussions featured 60 posters representing ten of the ASIP SIGs. The networking event and poster discussions were well attended and provided excellent opportunities for networking among members. In conjunction with SIG Night, the Liver Pathobiology Scientific Interest Group held a Club Hepatomania – Meet the Experts event. The featured experts included Stacey Huppert (Cincinnati Children’s Hospital), an expert in liver development, and Mark Czaja (Emory University School of Medicine).


Education and Career Development Sessions

The ASIP Education Committee and the Committee for Career Development and Diversity (CCDD) organized a total of six sessions on topics related to pathology education and career development. A popular event that was held on Saturday was the ASIP Highlight Session: I Am An ASIP Member and This is My Science, which featured short talks by eight Trailblazing Women and eight Trailblazing Men, as well as trainee poster presentations and discussions. The session was well attended and the short presentations by the selected members were interesting and informative for all. On Sunday, the XIXth Annual ASIP/AAA Career Development and Mentoring Program and Lunch (co-sponsored by the American Association of Anatomists) featured the topic of Giving and Responding to Critical Evaluations of Manuscripts and Grants. Dr. Martha Furie (Past President of the ASIP and Editor-in-Chief, The American Journal of Pathology) and Dr. Dan Remick (Past President of the ASIP and NIH Study Section Chair) were the featured speakers. This session provided attendees with practical advice regarding manuscript and grant critiques which challenge investigators at every stage of career. On Tuesday, the Lunch and Learn session was on the topic of Science, Dollars, and Outcomes: The Critical Pieces of Budgeting You Can’t Work Without. This popular session was organized by Dr. Dan Milner (ASCP) and included speakers from academic research and clinical service laboratories. All of the educational and career development sessions were extremely well done. Special thanks to members of the Education Committee and CCDD for organizing these sessions that provide a valuable professional development aspect to the Annual Meeting.


Career Central

At Experimental Biology 2019, the five organizing Societies collaborated to create Career Central, a resource for attendees at the meeting for various career development activities and events. The ASIP had a number of members participate in the Micro-Learning Hub short presentations – Drs. Linda McManus, Traci Parry, Kevin Gardner, and Greg Tsongalis. Special thanks to these ASIP members and to staff members from all the Societies that contributed time and effort to making sure Career Central provided value to the attendees.


More From Experimental Biology 2019

The 2019 Annual Meeting was captured in pictures by our tireless and talented photographer Elizabeth Walker (University of Michigan). Please feel free to browse the photo albums associated with the meeting and download pictures of yourself and others: EB2019 Day 1, EB2019 Day 2 (includes SIG Night), EB2019 Day 3 (includes the ASIP Business Meeting), and EB2019 Day 4. Additional photo albums include the Council Dinner, and the AJP Editorial Board Meeting. Special thanks to Liz for producing an exceptional picture archive for the meeting.


Save the Date: EB 2020 in San Diego CA

Experimental Biology 2019 is in the books and was a terrific meeting. Planning for next year’s meeting is already well underway. Save the date for the 2020 Annual Meeting of the ASIP: April 4-7, 2020 at Experimental Biology 2020 in San Diego, CA. It was great to see many of our members in Orlando and we hope to see you all in San Diego next year!